{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.18","upperLimit":"4586.18","value":"3.16"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Dopamine concentration at baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.82","upperLimit":"39.16","value":"3.70"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Dopamine concentration at completion of treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.20","upperLimit":"486.46","value":"6.43"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"}],"units":"Participants"}],"title":"Dopamine concentration at 12 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.04","upperLimit":"1093.28","value":"4.46"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"title":"Dopamine concentration at 24 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.11","upperLimit":"9.32","value":"4.05"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"title":"Dopamine concentration at 36 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.91","upperLimit":"11.24","value":"2.56"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"title":"3,4-dihydroxyphenylacetic acid concentration at baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.82","upperLimit":"9.91","value":"1.62"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"title":"3,4-dihydroxyphenylacetic acid concentration at completion of treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.51","upperLimit":"6.55","value":"1.04"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"title":"3,4-dihydroxyphenylacetic acid concentration at 12 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.31","upperLimit":"6.70","value":"1.52"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"title":"3,4-dihydroxyphenylacetic acid concentration at 24 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.38","upperLimit":"3.10","value":"1.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"3,4-dihydroxyphenylacetic acid concentration at 36 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.12","upperLimit":"13.94","value":"2.38"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"}],"units":"Participants"}],"title":"Hydroxytryptamine concentration at baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.06","upperLimit":"15.01","value":"2.01"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"}],"units":"Participants"}],"title":"Hydroxytryptamine concentration at completion of treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.06","upperLimit":"8.46","value":"2.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Hydroxytryptamine concentration at 12 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.01","upperLimit":"7.70","value":"2.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"title":"Hydroxytryptamine concentration at 24 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.29","upperLimit":"8.85","value":"1.62"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Hydroxytryptamine concentration at 36 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"30.02","upperLimit":"400.35","value":"52.03"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Hydroxyindoleacetic acid concentration at baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"27.42","upperLimit":"110.24","value":"52.72"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Hydroxyindoleacetic acid concentration at completion of treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"24.58","upperLimit":"51.60","value":"35.72"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Hydroxyindoleacetic acid concentration at 12 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.69","upperLimit":"45.63","value":"33.98"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Hydroxyindoleacetic acid concentration at 24 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.09","upperLimit":"53.04","value":"31.56"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Hydroxyindoleacetic acid concentration at 36 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"34.57","upperLimit":"565.30","value":"82.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Homovanillic acid concentration at baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"73.43","upperLimit":"179.21","value":"114.13"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Homovanillic acid concentration at completion of treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"40.78","upperLimit":"146.84","value":"68.28"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Homovanillic acid concentration at 12 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"55.27","upperLimit":"166.99","value":"88.27"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"title":"Homovanillic acid concentration at 24 months off treatment"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"35.40","upperLimit":"152.51","value":"79.78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Homovanillic acid concentration at 36 months off treatment"}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"}],"units":"Participants"}],"description":"Concentrations of various neurotransmitters in cerebrospinal fluid were measured at 5 timepoints. The median concentration of each neurotransmitter at each time point was calculated and provided with a full range.","dispersionType":"Full Range","groups":[{"description":"Patients with neurotransmitter studies","id":"OG000","title":"Patients With Neurotransmitter Studies"}],"paramType":"MEDIAN","populationDescription":"Eligible patients who had cerebrospinal fluid neurotransmitter studies performed. Seventeen patients had studies performed.","reportingStatus":"POSTED","timeFrame":"Baseline, at the completion of therapy, and every 12 months up to 36 months after off therapy date","title":"Concentration of Cerebrospinal Fluid Neurotransmitters","type":"SECONDARY","unitOfMeasure":"ng/ml"}